LA1007 - Technical Evaluation of Novel Heart Healthy Trans Fat Free, Tropical Fat Free Baking Ingredient made from Pure Soybean OilFundingThis project was funded through the Life Sciences and Innovation Fund. The Ministry and Agriculture and Agri-Food Canada (AAFC) jointly supported the Fund through the Agriculture Policy Framework. Such support does not indicate endorsement by the ministry or AAFC of the contents of the material. Lead researchersSteve Bernet and Dr. Alejandro Marangoni, Fractec Research and Development Inc. Objectives
Expected BenefitsThe report will include all the information that investors and customers
require as proof that the Fractec material has the characteristics required
as a heart-healthy competitive substitute for partially hydrogenated fats
and tropical oils. The information in the report will be used to promote
the technology and products to investors and customers. The information
obtained in the study will also be used for promotional and marketing
activities including promotional literature, whitepapers, websites, direct
sales, and tradeshows. The dedication and work of Fractec will ensure
that the results gained in the research are utilized commercially. The
market assessment will be used to develop a marketing plan that will provide
clear direction and help optimize the commercialization of the Fractec
material. ResultsCoaGel Corporation (Guelph, ON), with support from Guelph's world class Ontario life sciences and agri-food cluster, has commercialized a patented technology developed by Canadians that will have a positive impact on diets for people around the world. CoaGel's process creates Liquid Core Solid Lipid Nanoparticles (LC-SLNs) using a novel microencapsulation process. "This technology is clearly an "Ontario Agri-food Solution for a Global Health Problem. The Governments of Ontario and Canada have invested wisely in research, innovation, and support for entrepreneurial start-ups. It has established the right process to ensure its investment pays-off. This is clearly demonstrated by the CoaGel success story and proof that Ontarians have set the right course for a prosperous knowledge-based technology sector." (Steve Bernet, CoaGel VP) CoaGel has validated the utility of its shortening alternative in the marketplace, a critical step in bridging the gap between fundamental science and commercial reality. Some of the project highlights are listed below:
Related informationFor more information: Toll Free: 1-888-466-2372 ext. 64554 Local: (519) 826-4554 E-mail: research.omafra@ontario.ca
|
|||||||